Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Elite Pharms Inc (ELTP)

Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 Newsfile - Tue Jun 23, 6:08AM CDT

Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study Newsfile - Mon Jun 15, 6:00AM CDT

Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture,...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product Newsfile - Mon Jun 1, 6:14AM CDT

Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture,...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets Newsfile - Thu Apr 2, 7:10AM CDT

Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information Newsfile - Tue Feb 17, 3:22PM CST

Conference Call Scheduled for Wednesday, February 18 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"),...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 Newsfile - Wed Feb 11, 3:38PM CST

Financials for Third Quarter of Fiscal Year 2026 Ended December 31, 2025 will be released on Tuesday, February 17, 2026Northvale, New Jersey--(Newsfile Corp. - February 11, 2026) - Elite Pharmaceuticals,...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information Newsfile - Fri Nov 14, 2025

Conference Call Scheduled for Monday, November 17 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R) Newsfile - Wed Nov 12, 2025

Northvale, New Jersey--(Newsfile Corp. - November 12, 2025) - Elite Pharmaceuticals, Inc. (OTCBB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,...

ELTP : 0.3951 (+2.62%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 Newsfile - Mon Nov 10, 2025

Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025Northvale, New Jersey--(Newsfile Corp. - November 10, 2025) - Elite Pharmaceuticals,...

ELTP : 0.3951 (+2.62%)
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth Zacks Investment Research - Thu Aug 21, 2025

Shares of Elite Pharmaceuticals, Inc. ELTP have gained 6.3% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 Index’s 1.1% loss over the same time...

ELTP : 0.3951 (+2.62%)

Barchart Exclusives

Cerebras Stock Sold Off After Earnings. Investors Who Panic Sell Are Ignoring the Smart Money. Barchart - 51 minutes ago
Investors hit the sell button after earnings, but Morgan Stanley hit the upgrade button. Should panic sellers think twice? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.